Trial Information
Cervical Nodal Metastasis in Squamous Cell Carcinoma of the Head and Neck - Novel MRI, FDG-PET, and Histopathologic Correlation
Inclusion Criteria:
- Adult patients with newly diagnosed (biopsy-proven), untreated
squamous cell carcinoma (SCC) of the head and neck who will undergo neck dissection as
part of primary surgical therapy.
Exclusion Criteria:- A prior adverse reaction to the contrast/tracer agents being used in
the imaging methods being studied.
- Pregnancy.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
To evaluate the performance of novel imaging methods for detecting cervical nodal metastasis.
Outcome Time Frame:
pre and post surgery
Safety Issue:
No
Principal Investigator
Dr. Billy W. Loo Jr. M.D. Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Food and Drug Administration
Study ID:
ENT0011
NCT ID:
NCT00313027
Start Date:
November 2002
Completion Date:
March 2005
Related Keywords:
- Head and Neck Cancer
- Carcinoma, Squamous Cell
- Head and Neck Cancers
- Carcinoma
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |